Arno Therapeutics, Inc 5
5 · Arno Therapeutics, Inc · Filed Feb 17, 2015
Insider Transaction Report
Form 5
Zukiwski Alexander A
VP & Chief Medical Officer
Transactions
- Disposition to Issuer
2012 Series B Warrants (right to buy)
2014-10-28−62,500→ 0 totalExercise: $2.40From: 2013-10-29Exp: 2014-10-31→ Common Stock (62,500 underlying) - Award
2012 Series B Warrants (right to buy)
2014-10-28+62,500→ 62,500 totalExercise: $2.40From: 2013-10-29Exp: 2015-01-31→ Common Stock (62,500 underlying) - Disposition to Issuer
2013 Series E Warrants (right to buy)
2014-10-28−41,666→ 0 totalExercise: $2.40From: 2013-10-29Exp: 2014-10-31→ Common Stock (41,666 underlying) - Award
2013 Series E Warrants (right to buy)
2014-10-28+41,666→ 41,666 totalExercise: $2.40From: 2013-10-29Exp: 2015-01-31→ Common Stock (41,666 underlying)
Holdings
- 117,026
Common Stock
Footnotes (1)
- [F1]The two reported transactions resulted from the Issuer's unilateral extension of the expiration date of two outstanding warrants from 10/31/14 to 1/31/15. Such extension resulted in the deemed cancellation of the "originally" issued old warrant and the issuance of a replacement warrant. The Series B warrant was originally granted on 11/26/12 and the Series E warrant was originally granted on 10/29/13.